Founded in 1913, City of Hope began focusing on cancer research and treatment in the late 1940s. Receiving its NCI designation in 1981 and its designation as a comprehensive cancer center in 1998, City of Hope is today a biomedical research, treatment, and education center.
The Center’s more than 200 physicians and scientists are dedicated to developing innovative, disease-fighting strategies in the battle against cancer. In this multidisciplinary, interactive environment, basic, clinical, translational, and prevention and control scientists work closely together. Their work is a continuum, starting with research on the biomedical mechanisms of cancer genesis and progression, moving on to the development of new therapies, testing those treatments in clinical trials, and, finally, delivering the best in patient care and providing support and education to patients, their families, and the public. That work contributes to further understanding of cancer risk assessment and prevention. Examples of the basic research findings developed at City of Hope are recombinant DNA technology and monoclonal antibodies and these discoveries were then applied to therapy.
Read more about the City of Hope Comprehensive Cancer Center.
Beckman Research Institute
Director
Duarte, CA 1010-3000
Associate Director for Health Equity; Associate Director for Population Sciences Research
Associate Director, Education & Training
Associate Director for Plan to Enhance Diversity
Research Programs
Research Program | Program Leaders |
---|---|
Cancer Control and Population Sciences | Susan Neuhausen, PhD; Saro Armenian, DO, MPH |
Cancer Immunotherapeutics | Peter Lee, MD; Hua Yu, PhD |
Developmental Cancer Therapeutics | Miguel Villalona-Calero, MD; Sunil Sharma, MD, FACP, MBA |
Hematologic Malignancies | Stephen Forman, MD; Guido Marcucci, MD |
Molecular and Cellular Biology of Cancer | Binghui Shen, PhD; Charles Brenner, PhD |
Shared Resources
Category | Resource | Directors |
---|---|---|
Cat 1: Laboratory Science | Analytical Cytometry | Jeremy Stark, PhD |
Cat 1: Laboratory Science | Analytical Pharmacology | Timothy Synold, PharmD |
Cat 1: Laboratory Science | Drug Discovery and Structural Biology | John Williams, PhD; David Horne, PhD |
Cat 1: Laboratory Science | Integrated Mass Spectrometry | Patrick Pirrotte, PhD |
Cat 1: Laboratory Science | Integrative Genomics | Xiwei Wu, PhD; Jonathan Keats, PhD |
Cat 1: Laboratory Science | Light Microscopy and Digital Imaging | Brian Armstrong, PhD |
Cat 1: Laboratory Science | Research Pathology | Stanley Hamilton, MD |
Cat 1: Laboratory Science | Small Animal Studies | Anna Wu, PhD; Jun Wu, PhD |
Cat 4: Clinical Research | GMP Manufacturing | David Horne, PhD; Taby Ahsan, PhD |
Cat 6: Biostatistics | Biostatistics and Mathematical Oncology | Joycelynne Palmer, PhD; Russell Rockne, PhD |
Cat 8: Miscellaneous | Population Facing Research | Victoria Seewaldt, MD |